ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987

August 1, 1986

Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded

April 19, 1985